Genome British Columbia (Genome BC), a not-for-profit genomics research company, has secured $49 million in funding for five projects that will be conducted in British Columbia and will utilize genomics to advance personalized healthcare.
According to Genome BC, the projects are part of research funding announced in March by Genome Canada under the Canadian Precision Health Initiative (CPHI). ...
Variantyx, a startup focused on using precision medicine technology in genomic testing, announced a $41.5 million C-2 funding round. New Era Capital Partners led the round with participation from Peregrine Ventures, Robert Bosch Ventures Capital, 20/20 HealthCare Partners and Pitango HealthTech.
This news comes just under a year after the Massachusetts-based company closed its $20 million Series...
Digital technologies have filtered into nearly every facet of medicine, from drug discovery all the way to consumer fitness. But digital health isn't the only relative newcomer that could disrupt the status quo in health. The precision genomics space is also growing in popularity and use.
What is precision genomics, and how will this space work with digital health?
Precision genomics medicine...
